Clinical Trials Browser

Phase EARLY_PHASE1 × Immune Checkpoint Inhibitors × Other hematologic neoplasm × Clear all

NCT06980155 2025-05-20

XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute